Methods of treating androgen receptor-mediated disorders with imidazoline derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9895355
SERIAL NO

15411517

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for treating androgen receptor-mediated diseases, such as breast cancer, with imidazoline derivatives of formula (I) are provided:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI HENGRU PHARMACEUTICAL CO LTDSHANGHAI

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dong, Qing Shanghai, CN 131 1314
Fei, Hongbo Shanghai, CN 8 14
Jiang, Hongjian Shanghai, CN 21 98
Lu, Hejun Shanghai, CN 8 17
Sun, Piaoyang Jiangsu, CN 52 122
Wang, Haowei Shanghai, CN 34 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00